HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

New mutations in APOB100 involved in familial hypobetalipoproteinemia.

Abstract
Familial hypolipoproteinemia (FHBL) is characterized by an inherited low plasma level of apolipoprotein B containing lipoproteins. FHBL may be caused by mutations of APOB. Individuals with FHBL typically have intestinal malabsorption and frequently suffer from a deficiency of fat-soluble vitamins. Most mutations that cause FHBL are APOB truncating mutations. Here we describe a patient with FHBL caused by a novel truncating mutation together with a novel missense mutation.
AuthorsKlaus Brusgaard, Lars Kjaersgaard, Anne-Birthe Bo Hansen, Steffen Husby
JournalJournal of clinical lipidology (J Clin Lipidol) 2010 May-Jun Vol. 4 Issue 3 Pg. 181-4 ISSN: 1933-2874 [Print] United States
PMID21122650 (Publication Type: Case Reports, Journal Article)
CopyrightCopyright © 2010 National Lipid Association. Published by Elsevier Inc. All rights reserved.
Chemical References
  • Apolipoprotein B-100
  • Codon, Nonsense
  • Vitamin A
  • Vitamin E
Topics
  • Amino Acid Substitution
  • Apolipoprotein B-100 (blood, deficiency, genetics)
  • Child
  • Codon, Nonsense
  • Female
  • Humans
  • Hypobetalipoproteinemia, Familial, Apolipoprotein B (blood, drug therapy, genetics)
  • Mutation
  • Mutation, Missense
  • Vitamin A (therapeutic use)
  • Vitamin E (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: